Unlock stock picks and a broker-level newsfeed that powers Wall Street.
73.79
+0.95
+(1.30%)
At close: March 28 at 4:00:00 PM EDT
73.75
-0.04
(-0.06%)
After hours: March 28 at 7:50:49 PM EDT
Research Analysis
Earnings Estimate
| Currency in USD | Current Qtr. (Mar 2025) | Next Qtr. (Jun 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| No. of Analysts | 2 | 2 | 4 | 4 |
| Avg. Estimate | 1.1 | 1.11 | 4.42 | 5.07 |
| Low Estimate | 1.09 | 1.11 | 4.34 | 4.97 |
| High Estimate | 1.11 | 1.12 | 4.48 | 5.21 |
| Year Ago EPS | 1.03 | 0.99 | 4.11 | 4.42 |
Revenue Estimate
| Currency in USD | Current Qtr. (Mar 2025) | Next Qtr. (Jun 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| No. of Analysts | 8 | 6 | 24 | 24 |
| Avg. Estimate | 13.71B | 13.92B | 57.23B | 60.71B |
| Low Estimate | 13.34B | 13.67B | 53.93B | 55.89B |
| High Estimate | 13.93B | 14.48B | 59.66B | 66.5B |
| Year Ago Sales | 12.68B | 12.94B | 54.07B | 57.23B |
| Sales Growth (year/est) | 8.11% | 7.60% | 5.85% | 6.07% |
Earnings History
| Currency in USD | 3/31/2024 | 6/30/2024 | 9/30/2024 | 12/31/2024 |
|---|---|---|---|---|
| EPS Est. | 0.95 | 0.99 | 1.03 | 1.04 |
| EPS Actual | 1.03 | 0.99 | 1.04 | 1.04 |
| Difference | 0.08 | -0 | 0.01 | 0.01 |
| Surprise % | 8.42% | -0.38% | 1.13% | 0.84% |
EPS Trend
| Currency in USD | Current Qtr. (Mar 2025) | Next Qtr. (Jun 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| Current Estimate | 1.1 | 1.11 | 4.42 | 5.07 |
| 7 Days Ago | 1.09 | 1.15 | 4.42 | 5.07 |
| 30 Days Ago | 1.03 | 1.1 | 4.46 | 5.04 |
| 60 Days Ago | 1.11 | 1.23 | 4.72 | 5.61 |
| 90 Days Ago | 1.11 | 1.23 | 4.78 | 5.64 |
EPS Revisions
| Currency in USD | Current Qtr. (Mar 2025) | Next Qtr. (Jun 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| Up Last 7 Days | 1 | 1 | -- | -- |
| Up Last 30 Days | -- | -- | -- | -- |
| Down Last 7 Days | -- | -- | 4 | 2 |
| Down Last 30 Days | 1 | 1 | 4 | 2 |
Growth Estimates
| Current Qtr. | Next Qtr. | Current Year | Next Year | |
|---|---|---|---|---|
| AZN | 6.91% | 12.61% | 7.78% | 14.58% |
| S&P 500 | 16.20% | 6.69% | 10.00% | 14.33% |
Upgrades & Downgrades
| Upgrade | UBS: Neutral to Buy | 2/13/2025 |
| Upgrade | UBS: Sell to Neutral | 11/20/2024 |
| Upgrade | Erste Group: Hold to Buy | 9/11/2024 |
| Maintains | TD Cowen: Buy to Buy | 8/12/2024 |
| Maintains | Argus Research: Buy to Buy | 5/30/2024 |
| Initiated | Goldman Sachs: Buy | 5/30/2024 |
Related Tickers
SNY Sanofi
55.82
+1.66%
NVS Novartis AG
112.57
+1.05%
GSK GSK plc
38.74
+0.57%
AMGN Amgen Inc.
306.95
+0.39%
BMY Bristol-Myers Squibb Company
60.02
+1.90%
GILD Gilead Sciences, Inc.
111.79
+0.57%
MRK Merck & Co., Inc.
89.23
+1.86%
JNJ Johnson & Johnson
163.71
+0.36%
RHHBY Roche Holding AG
41.92
-1.34%
ABBV AbbVie Inc.
205.29
+1.27%